TRIM21 and dermatomyositis: • Baseline CRP > 5 mg/L, serum ferritin > 600 ng/ml and positive anti-Ro52 antibody are risk factors for death in anti-MDA5-DM patients, and prophylactic use of compound sulfamethoxazole is protective.